7.400
-0.130
(-1.73%)
At close: 4:08:01 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
7,468,990
7,468,990
8,013,285
9,150,347
8,337,221
Cost of Revenue
2,046,796
2,046,796
1,904,119
2,114,500
2,090,283
Gross Profit
5,422,194
5,422,194
6,109,166
7,035,847
6,246,938
Operating Expense
3,689,680
3,689,680
3,277,487
3,390,292
3,030,809
Operating Income
1,732,514
1,732,514
2,831,679
3,645,555
3,216,129
Net Non Operating Interest Income Expense
87,734
87,734
100,224
56,429
53,583
Pretax Income
2,010,307
2,010,307
2,873,771
3,762,850
3,456,589
Tax Provision
397,227
397,227
489,341
486,655
431,325
Net Income Common Stockholders
1,619,788
1,619,788
2,400,940
3,258,992
3,017,402
Diluted NI Available to Com Stockholders
1,619,788
1,619,788
2,400,940
3,258,992
3,017,402
Basic EPS
0.57
0.67
0.98
1.33
1.22
Diluted EPS
0.57
0.67
0.98
1.33
1.22
Basic Average Shares
2,445,172.056
2,427,382.419
2,451,988.512
2,453,940.224
2,467,696.556
Diluted Average Shares
2,445,172.056
2,427,382.419
2,451,988.512
2,453,940.224
2,467,696.556
Total Expenses
5,736,476
5,736,476
5,181,606
5,504,792
5,121,092
Net Income from Continuing & Discontinued Operation
1,619,788
1,619,788
2,400,940
3,258,992
3,017,402
Normalized Income
1,693,569.924
1,693,569.924
2,725,921.225
3,206,343.167
2,962,686.511
Interest Income
126,344
126,344
146,475
105,515
81,853
Interest Expense
38,610
38,610
46,251
49,086
28,270
Net Interest Income
87,734
87,734
100,224
56,429
53,583
EBIT
2,048,917
2,048,917
2,920,022
3,811,936
3,484,859
EBITDA
2,048,917
2,308,155
3,149,587
4,039,162
3,704,679
Reconciled Cost of Revenue
2,046,796
2,046,796
1,904,119
2,114,500
2,090,283
Reconciled Depreciation
--
259,238
229,565
227,226
219,820
Net Income from Continuing Operation Net Minority Interest
1,619,788
1,619,788
2,400,940
3,258,992
3,017,402
Total Unusual Items Excluding Goodwill
-91,951
-91,951
-391,675
129,382
85,368
Total Unusual Items
-91,951
-91,951
-391,675
189,382
105,368
Normalized EBITDA
2,140,868
2,400,106
3,541,262
3,849,780
3,599,311
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-18,169.076
-18,169.076
-66,693.775
16,733.167
10,652.511
12/31/2021 - 9/28/2010
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
0512.HK GRAND PHARMA
5.600
-3.45%
3320.HK China Resources Pharmaceutical Group Limited
4.960
-1.20%
0719.HK SHANDONG XINHUA
5.500
0.00%
2552.HK Hua Medicine (Shanghai) Ltd.
2.050
+0.49%
1061.HK ESSEX BIO-TECH
4.450
-3.05%
COLL Collegium Pharmaceutical, Inc.
26.73
+1.63%
VTRS Viatris Inc.
7.63
+1.19%
ZTS Zoetis Inc.
150.83
+0.93%